Interim Report July–September 2016: Q3 highlights include new product launches, high growth and a Faun Pharma sales record
The third quarter summary for Zinzino AB (publ) in 2016 shows sustained growth and a continued increase in profitability. A number of important objectives have also been achieved, most notably a growth of 20%, the launch of 19 new EU markets and registering 100,000 customers. During this period new products were also launched and Faun Pharma in Norway set a new sales record in October.Commenting on the report, Dag Bergheim Pettersen, CEO of Zinzino said, ”Reaching 100,000 customers was an important milestone. It has taken us 10 years to reach this number and our ambition now is to reach